NCT04358289

Brief Summary

The study aims to develop community-based interventions targetting inappropriate antibiotic dispensing and use behaviours in rural Vietnam and has 3 research components. Community and primary healthcare interventions: The investigators will conduct a four-armed cluster randomised controlled trial. The first arm will be a control arm with no interventions. The second intervention arm will have a basic antimicrobial stewardship intervention, involving working with the Ministry of Health, Medical Services Administration to revise guidelines for antibiotic prescribing for acute respiratory infections (ARI) in primary care, and then training primary healthcare doctors in their use. The third intervention arm will have basic antimicrobial stewardship guidelines and training for primary healthcare doctors, plus educational materials for the community, disseminated through posters, leaflets and local media channels. The fourth intervention arm will use a participatory action research approach to engage primary healthcare doctors and communities, in addition to the basic guidelines and training materials. The participatory action research approach will train local facilitators to lead community and health-worker groups through a cycle of problem identification, strategy development, implementation and review, focusing on inappropriate human and small-scale agricultural use of antibiotics. Hospital interventions: The investigators will work with Provincial and District Hospitals serving these communities to implement quality improvement cycles for antibiotic stewardship, also using a participatory action research approach. This will also follow a cycle of a cycle of problem identification, strategy development, implementation and review.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,315

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Feb 2020Sep 2026

Study Start

First participant enrolled

February 27, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 3, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

December 6, 2023

Status Verified

December 1, 2023

Enrollment Period

6.5 years

First QC Date

April 3, 2020

Last Update Submit

December 5, 2023

Conditions

Keywords

AMRprimary health careAntimicrobial resistance

Outcome Measures

Primary Outcomes (6)

  • Community: Proportion of the population reporting antibiotic use in the last month

    After the last interview/survey, up to 18 months since study implementation

  • Community: Proportion of the population with a mild respiratory illness in the last month who didn't seek medical consultation and treatment (at a health facility or a pharmacy)

    After the last interview/survey, up to 18 months since study implementation

  • Community: Proportion of farmers reporting antibiotic use for their animals in the last month

    After the last interview/survey, up to 18 months since study implementation

  • Primary healthcare: Proportion of patients aged 1 to 65 years, consulting for ARI, who are prescribed antibiotics

    After the last interview/survey, up to 18 months since study implementation

  • Primary healthcare: Proportion of the population reporting antibiotic use in the last month

    After the last interview/survey, up to 18 months since study implementation

  • Hospital: Proportion of patients receiving antibiotic treatment in the three months preceding the survey

    After the last interview/survey, up to 18 months since study implementation

Secondary Outcomes (25)

  • Community: Proportion of the population who have heard about antibiotic resistance

    After the last interview/survey, up to 18 months since study implementation

  • Community: Proportion of the population who can correctly define antibiotic resistance (from a list of options)

    After the last interview/survey, up to 18 months since study implementation

  • Community: Proportion of the population who can correctly identify at least two human health behaviours that can lead to antibiotic resistance (from a list of options)

    After the last interview/survey, up to 18 months since study implementation

  • Community: Average number of days of illness in the last month

    After the last interview/survey, up to 18 months since study implementation

  • Community: Average number of days unable to do usual activities due to illness (e.g. absent from school/work/farm work) in the last month

    After the last interview/survey, up to 18 months since study implementation

  • +20 more secondary outcomes

Study Arms (5)

Arm 1: Control group

NO INTERVENTION

For commune health center and community

Arm 2: Basic antimicrobial stewardship education

OTHER

For commune health center and community

Other: Basic antimicrobial stewardship education

Arm 3: 3. Basic AS education + community education

OTHER

For commune health center and community

Other: Basic antimicrobial stewardship educationOther: Community education

Arm 4: Education + participatory action research

OTHER

For commune health center and community

Other: Basic antimicrobial stewardship educationOther: Participatory action research group in commune health center and communityOther: Community education

Hospital intervention

OTHER

For hospital: The hospital interventions will use quality improvement using a participatory action research approach to improve antibiotic stewardship. These activities will be evaluated through a before and after knowledge, attitudes and practice (KAP) survey, to assess whether or not the engagement activities had a measurable impact on knowledge and behaviour. There are not sufficient hospitals in the area to conduct a cluster randomized evaluation, so we will conduct a before and after survey, patient record review, and overall antibiotic use data from the Pharmacy Department

Other: Antimicrobial stewardship program in hospitals

Interventions

Commune health center: Revision of guidelines for antibiotic prescribing for respiratory infections in primary care, Training primary healthcare doctors in the application of the new guidelines

Arm 2: Basic antimicrobial stewardship educationArm 3: 3. Basic AS education + community educationArm 4: Education + participatory action research

* Establish a participatory action research group * Engagement with the group through participatory action research involving problem identification, planning change strategies, implementing strategies, and evaluation

Arm 4: Education + participatory action research

The intervention activities in hospitals will include: training a health-worker in each of the participating hospitals to act as a facilitator or "activator"; forming an antibiotic stewardship group; meeting regularly and following an action-research cycle that includes problem identification, planning change strategies, implementing strategies, and evaluating strategies

Hospital intervention

Development of educational materials for the community and farmers; Disseminated of messages through posters, leaflets and local media channels

Arm 3: 3. Basic AS education + community educationArm 4: Education + participatory action research

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Commune officials consent to take part;
  • Have a commune population larger than 3000 individuals;
  • Have active Women's Union and Farmers' Union groups with a paid commune-level representative;
  • Commune health centre has a doctor;
  • Commune health centre has electronic database.

You may not qualify if:

  • Urban areas with a low proportion of farmers or low utilisation of CHCs for primary healthcare.
  • For study participants:
  • Participant is willing and able to give informed consent for participation in the study;
  • Community members normally resident in the study commune (living in the study commune and resident for at least three months);
  • No one will be actively excluded from participating in this population-based study.
  • For Commune Health Centers:
  • Serve a commune population larger than 3000 individuals;
  • Have an average caseload of at least 10 consultations per facility per week for ARI verified by checking the database system of the provincial centre for disease control and prevention (CDC) where the implementation study is being conducted;
  • Health centre doctor is normally employed at the centre and has been there for at least three months.
  • Low antibiotic prescription rate for ARI of below 40%.
  • For Patient records:
  • All patients' anonymised records.
  • Don't have national health insurance/not recorded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nam Dinh province

Nam Định, 07000, Vietnam

RECRUITING

MeSH Terms

Interventions

Residence CharacteristicsHospitals

Intervention Hierarchy (Ancestors)

DemographyPopulation CharacteristicsEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthHealth FacilitiesHealth Care Facilities Workforce and Services

Central Study Contacts

Sonia Lewycka, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2020

First Posted

April 24, 2020

Study Start

February 27, 2020

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

December 6, 2023

Record last verified: 2023-12

Locations